This inventor holds 2 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 2009-2018.
Location History:
- Stanford, CA (US) (2009)
- Palo Alto, CA (US) (2018)
Company Filing History:
Years Active: 2009-2018
Title: Mark Musen: Innovator in Pharmacogenomics and Laboratory Management
Introduction
Mark Musen is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the fields of pharmacogenomics and laboratory data management. With a total of 2 patents, Musen's work focuses on enhancing the extraction and normalization of relationships in scientific data.
Latest Patents
Musen's latest patents include a "Method and system for extraction and normalization of relationships via ontology induction." This invention describes methods for developing an ontology of pharmacogenomics (PGx) relationships, starting from a lexicon of key pharmacogenomic entities. The invention systematically extracts commonly occurring relationships and maps them to a common schema, achieving a precision of 70-87.7%. It involves key PGx entities such as genes, drugs, and phenotypes, as well as critical entities frequently modified by these key entities.
Another notable patent is the "System and method for internet-accessible tools and knowledge base for protocol design, metadata capture, and laboratory experiment management." This invention relates to databases and the exchange of scientific information. It includes a laboratory data management system with a knowledge base that stores characteristics of laboratory reagents, experiment subjects, tissues, and cells. The system also features an experiment input module and a protocol creator that generates laboratory protocols based on data supplied from the knowledge base.
Career Highlights
Mark Musen is affiliated with Leland Stanford Junior University, where he continues to advance research in his areas of expertise. His innovative approaches have significantly impacted the way laboratory experiments are managed and how pharmacogenomic relationships are understood.
Collaborations
Musen has collaborated with notable colleagues, including James Tung and Yael Garten. Their combined efforts contribute to the advancement of scientific knowledge and the development of innovative solutions in their respective fields.
Conclusion
Mark Musen's contributions to pharmacogenomics and laboratory management exemplify the importance of innovation in scientific research. His patents reflect a commitment to improving the efficiency and accuracy of data management in laboratories.